Cancer therapy | KAIST MatriX

Tag: Cancer therapy

Research Highlight

A Peptide-Antibody Hybrid Platform for Targeted Cancer Therapy

Synergy in hybrid-A new hybrid platform is developed based on a hapten-labeled bispecific peptide and an anti-hapten antibody to overcome the short plasma half-life of most peptide therapeutics....read more

Antibodies Biologics Cancer Metastasis Control Cancer therapy Drug delivery KAIST Institute for the BioCentury Peptides

Research Highlight

Decorating Tumor Cell Membranes with Synthetic Receptors to Improve Targeted Cancer Therapy

Delivery of synthetic receptors to tumor cell membranes using both synthetic and biological nanoparticles led to effective treatment of cancer....read more

Cancer therapy Drug delivery KIHST Synthetic receptor Targeting

Copyright © 2015 KAIST MATRIX. All rights reserved.
291 Daehak-ro Yuseong-gu Daejeon, 34141, Republic of Korea
Partnered with KAIST Breakthroughs and KAIST Compass